Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 2/2019

Ausgabe 2/2019

Inhaltsverzeichnis ( 26 Artikel )

06.08.2019 | Preclinical study | Ausgabe 2/2019

Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases

Zhe-Bin Liu, Nader E. Ezzedine, Agda K. Eterovic, Joe E. Ensor, Helen J. Huang, Joan Albanell, Dong S. Choi, Ana Lluch, Yi Liu, Federico Rojo, Helen Wong, Eduardo Martínez-Dueñas, Ángel Guerrero-Zotano, Zhi-Min Shao, Jorge G. Darcourt, Gordon B. Mills, Bhuvanesh Dave, Jenny C. Chang

06.08.2019 | Preclinical study | Ausgabe 2/2019 Open Access

Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer

Jichao He, Ronan P. McLaughlin, Vera van der Noord, John A. Foekens, John W. M. Martens, Gerard van Westen, Yinghui Zhang, Bob van de Water

06.08.2019 | Preclinical study | Ausgabe 2/2019 Open Access

HER2 double-equivocal breast cancer in Chinese patients: a high concordance of HER2 status between different blocks from the same tumor

Yuanyuan Liu, Shafei Wu, Xiaohua Shi, Yufeng Luo, Junyi Pang, Changjun Wang, Feng Mao, Zhiyong Liang, Xuan Zeng

12.08.2019 | Preclinical study | Ausgabe 2/2019

Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer

Akira I. Hida, Takahiro Watanabe, Yasuaki Sagara, Masahiro Kashiwaba, Yoshiaki Sagara, Kenjiro Aogi, Yasuyo Ohi, Akihide Tanimoto

13.08.2019 | Preclinical study | Ausgabe 2/2019

Evaluation of phospho-histone H3 in Asian triple-negative breast cancer using multiplex immunofluorescence

Chi Peng Timothy Lai, Joe Poh Sheng Yeong, An Sen Tan, Chong Hui Clara Ong, Bernett Lee, Jeffrey Chun Tatt Lim, Aye Aye Thike, Jabed Iqbal, Rebecca Alexandra Dent, Elaine Hsuen Lim, Puay Hoon Tan

17.08.2019 | Preclinical study | Ausgabe 2/2019

Genomic landscape of ductal carcinoma in situ and association with progression

Chieh-Yu Lin, Sujay Vennam, Natasha Purington, Eric Lin, Sushama Varma, Summer Han, Manisha Desa, Tina Seto, Nicholas J. Wang, Henning Stehr, Megan L. Troxell, Allison W. Kurian, Robert B. West

20.08.2019 | Preclinical study | Ausgabe 2/2019 Open Access

Gene expression analysis to detect disseminated tumor cells in the bone marrow of triple-negative breast cancer patients predicts metastatic relapse

Chidananda M. Siddappa, Sreeraj G. Pillai, Jackie Snider, Patsy Alldredge, Kathyrn Trinkaus, Mark A. Watson, Rebecca Aft

07.08.2019 | Clinical trial | Ausgabe 2/2019

A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients

Angel Arnaout, Susan J. Robertson, Gregory R. Pond, Hoyun Lee, Ahwon Jeong, Luisa Ianni, Lynne Kroeger, John Hilton, Stuart Coupland, Chloe Gottlieb, Bernard Hurley, Anne McCarthy, Mark Clemons

07.08.2019 | Clinical trial | Ausgabe 2/2019

A multicentre, randomized pilot trial comparing vascular access strategies for early stage breast cancer patients receiving non-trastuzumab containing chemotherapy

Andrew Robinson, Carol Stober, Dean Fergusson, Anne Kehoe, Debbie Bedard, Fiona MacDonald, Marie-Claude Brunet, Deanna Saunders, Sasha Mazzarello, Lisa Vandermeer, Anil A. Joy, Arif Awan, Bassam Basulaiman, Ranjeeta Mallick, Brian Hutton, Mark Clemons, the REaCT investigators

09.08.2019 | Clinical trial | Ausgabe 2/2019

Randomized window of opportunity trial evaluating high-dose vitamin D in breast cancer patients

Angel Arnaout, Susan Robertson, Gregory R. Pond, Reinhold Vieth, Ahwon Jeong, John Hilton, Timothy Ramsey, Mark Clemons

09.08.2019 | Clinical trial | Ausgabe 2/2019

Phase II randomized controlled trial of hypnosis versus progressive muscle relaxation for body image after breast or gynecologic cancer

Debra L. Barton, Trevor M. Brooks, Alison Cieslak, Gary R. Elkins, Patricia M. Clark, Mohamad Baydoun, Asa B. Smith, Catherine H. Van Poznak

12.08.2019 | Clinical trial | Ausgabe 2/2019

Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11)

Ji-Yeon Kim, Eunjin Lee, Kyunghee Park, Seock-Ah Im, Joohyuk Sohn, Keun Seok Lee, Yee Soo Chae, Jee Hyun Kim, Tae-Yong Kim, Kyung Hae Jung, Yeon Hee Park, the Breast Cancer Committee of the Korean Cancer Study Group

14.08.2019 | Clinical trial | Ausgabe 2/2019 Open Access

Marital status is an independent prognostic factor in inflammatory breast cancer patients: an analysis of the surveillance, epidemiology, and end results database

Yan-ling Liu, Dun-wei Wang, Zhu-chun Yang, Rui Ma, Zhong Li, Wei Suo, Zhuang Zhao, Zhi-wen Li

19.08.2019 | Clinical trial | Ausgabe 2/2019 Open Access

Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination

Sandra M. Swain, Gong Tang, Peter C. Lucas, André Robidoux, David Goerlitz, Brent T. Harris, Hanna Bandos, Charles E. Geyer Jr., Priya Rastogi, Eleftherios P. Mamounas, Norman Wolmark

20.08.2019 | Clinical trial | Ausgabe 2/2019

Long-term outcome with targeted therapy in advanced/metastatic HER2-positive breast cancer: The Royal Marsden experience

Nicolò Matteo Luca Battisti, Daniel Tong, Alistair Ring, Ian Smith

06.08.2019 | Epidemiology | Ausgabe 2/2019 Open Access

Reliability of preoperative breast biopsies showing ductal carcinoma in situ and implications for non-operative treatment: a cohort study

Gurdeep S. Mannu, Emma J. Groen, Zhe Wang, Michael Schaapveld, Esther H. Lips, Monica Chung, Ires Joore, Flora E. van Leeuwen, Hendrik J. Teertstra, Gonneke A. O. Winter-Warnars, Sarah C. Darby, Jelle Wesseling

10.08.2019 | Epidemiology | Ausgabe 2/2019

Utilization, duration, and outcomes of neoadjuvant endocrine therapy in the United States

Ashley C. Pariser, Tannaz Sedghi, Pamela R. Soulos, Brigid Killelea, Cary P. Gross, Sarah S. Mougalian

13.08.2019 | Epidemiology | Ausgabe 2/2019

Allelic modification of breast cancer risk in women with an NBN mutation

Bogna Rusak, Wojciech Kluźniak, Dominika Wokołorczyk, Klaudia Stempa, Aniruddh Kashyap, Helena Rudnicka, Jacek Gronwald, Tomasz Huzarski, Tadeusz Dębniak, Anna Jakubowska, Marek Szwiec, Mohammad R. Akbari, Steven A. Narod, Jan Lubiński, Cezary Cybulski, the Polish Hereditary Breast Cancer Consortium

14.08.2019 | Epidemiology | Ausgabe 2/2019

Differences in breast cancer outcomes amongst Black US-born and Caribbean-born immigrants

Priscila Barreto-Coelho, Danielle Cerbon, Matthew Schlumbrecht, Carlos M. Parra, Judith Hurley, Sophia H. L. George

14.08.2019 | Epidemiology | Ausgabe 2/2019

Time-to-surgery and overall survival after breast cancer diagnosis in a universal health system

Yvonne L. Eaglehouse, Matthew W. Georg, Craig D. Shriver, Kangmin Zhu

17.08.2019 | Epidemiology | Ausgabe 2/2019 Open Access

Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes

Giuseppe Viale, Amy E. Hanlon Newell, Espen Walker, Greg Harlow, Isaac Bai, Leila Russo, Patrizia Dell’Orto, Patrick Maisonneuve

20.08.2019 | Epidemiology | Ausgabe 2/2019 Open Access

Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer

Christine Lundgren, Pär-Ola Bendahl, Åke Borg, Anna Ehinger, Cecilia Hegardt, Christer Larsson, Niklas Loman, Martin Malmberg, Helena Olofsson, Lao H. Saal, Tobias Sjöblom, Henrik Lindman, Marie Klintman, Jari Häkkinen, Johan Vallon-Christersson, Mårten Fernö, Lisa Rydén, Maria Ekholm

07.08.2019 | Brief Report | Ausgabe 2/2019

Rationale for evaluating breast cancers of Lynch syndrome patients for mismatch repair gene expression

Steven Sorscher

09.08.2019 | Brief Report | Ausgabe 2/2019

Effect of early adverse events resulting in ado-trastuzumab emtansine dose adjustments on survival outcomes of HER2+ advanced breast cancer patients

Ethan Tang, Andrew Rowland, Ross A. McKinnon, Michael J. Sorich, Ashley M. Hopkins

19.08.2019 | Letter to the Editor | Ausgabe 2/2019

Precision medicine: PI3K targeting in advanced breast cancer

Andrea Rocca, Elisabetta Melegari, Michela Palleschi

20.08.2019 | Letter to the Editor | Ausgabe 2/2019

Letter regarding Sopik V et al. entitled “Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ”

Xiangyu Wang, Xiangyi Kong, Yi Fang, Jing Wang

Aktuelle Ausgaben